Ne during Bottleneck | Admixture Proportion (%)a | Gene Flow (Effective Donors per Generation)b | Duration of Gene Flow (Generation) | |||||
Models | EUR & EASc | EURd | EASe | EUR | EAS | EUR | EAS | |
Model 1 | N | N | N | — | — | — | — | — |
Model 1a | N | N | N | — | — | — | — | — |
Model 1b | 500–1,000 | N | N | — | — | — | — | — |
Model 1c | N | 100–300 | 100–300 | — | — | — | — | — |
Model 1d | 500–1,000 | 100–300 | 100–300 | — | — | — | — | — |
Model 2 | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2a | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2b | 500–1,000 | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2c | N | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 2d | 500–1,000 | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 3 | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3a | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3b | 500–1,000 | N | N | 50–60 | 50–40 | — | — | — |
Model 3c | N | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 3d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 4 | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4a | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4b | 500–1,000 | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4c | N | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Ne during Bottleneck | Admixture Proportion (%)a | Gene Flow (Effective Donors per Generation)b | Duration of Gene Flow (Generation) | |||||
Models | EUR & EASc | EURd | EASe | EUR | EAS | EUR | EAS | |
Model 1 | N | N | N | — | — | — | — | — |
Model 1a | N | N | N | — | — | — | — | — |
Model 1b | 500–1,000 | N | N | — | — | — | — | — |
Model 1c | N | 100–300 | 100–300 | — | — | — | — | — |
Model 1d | 500–1,000 | 100–300 | 100–300 | — | — | — | — | — |
Model 2 | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2a | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2b | 500–1,000 | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2c | N | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 2d | 500–1,000 | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 3 | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3a | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3b | 500–1,000 | N | N | 50–60 | 50–40 | — | — | — |
Model 3c | N | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 3d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 4 | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4a | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4b | 500–1,000 | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4c | N | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Ancestry contribution of EUR ranges from 50% to 60%, whereas that of EAS ranges from 50% to 40% so that in each single simulation the admixture proportions summed to 100% (see Materials and Methods for details).
Gene flow was simulated under the CGF model (see Materials and Methods for details).
Bottleneck shared by EUR and EAS before they diverged; Ne of 500, 600, … 1,000 were simulated; N denotes no bottleneck was simulated.
Bottleneck occurred in EUR after the divergence of EUR and EAS, Ne of 100, 200, and 300 were simulated; N denotes no bottleneck was simulated.
Bottleneck occurred in EAS after the divergence of EUR and EAS, Ne of 100, 200, and 300 were simulated; N denotes no bottleneck was simulated.
Ne during Bottleneck | Admixture Proportion (%)a | Gene Flow (Effective Donors per Generation)b | Duration of Gene Flow (Generation) | |||||
Models | EUR & EASc | EURd | EASe | EUR | EAS | EUR | EAS | |
Model 1 | N | N | N | — | — | — | — | — |
Model 1a | N | N | N | — | — | — | — | — |
Model 1b | 500–1,000 | N | N | — | — | — | — | — |
Model 1c | N | 100–300 | 100–300 | — | — | — | — | — |
Model 1d | 500–1,000 | 100–300 | 100–300 | — | — | — | — | — |
Model 2 | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2a | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2b | 500–1,000 | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2c | N | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 2d | 500–1,000 | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 3 | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3a | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3b | 500–1,000 | N | N | 50–60 | 50–40 | — | — | — |
Model 3c | N | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 3d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 4 | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4a | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4b | 500–1,000 | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4c | N | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Ne during Bottleneck | Admixture Proportion (%)a | Gene Flow (Effective Donors per Generation)b | Duration of Gene Flow (Generation) | |||||
Models | EUR & EASc | EURd | EASe | EUR | EAS | EUR | EAS | |
Model 1 | N | N | N | — | — | — | — | — |
Model 1a | N | N | N | — | — | — | — | — |
Model 1b | 500–1,000 | N | N | — | — | — | — | — |
Model 1c | N | 100–300 | 100–300 | — | — | — | — | — |
Model 1d | 500–1,000 | 100–300 | 100–300 | — | — | — | — | — |
Model 2 | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2a | N | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2b | 500–1,000 | N | N | — | — | 2 | 1–2 | 2,000 |
Model 2c | N | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 2d | 500–1,000 | 100–300 | 100–300 | — | — | 2 | 1–2 | 2,000 |
Model 3 | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3a | N | N | N | 50–60 | 50–40 | — | — | — |
Model 3b | 500–1,000 | N | N | 50–60 | 50–40 | — | — | — |
Model 3c | N | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 3d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | — | — | — |
Model 4 | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4a | N | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4b | 500–1,000 | N | N | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4c | N | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Model 4d | 500–1,000 | 100–300 | 100–300 | 50–60 | 50–40 | 46–35 | 26–35 | 100 |
Ancestry contribution of EUR ranges from 50% to 60%, whereas that of EAS ranges from 50% to 40% so that in each single simulation the admixture proportions summed to 100% (see Materials and Methods for details).
Gene flow was simulated under the CGF model (see Materials and Methods for details).
Bottleneck shared by EUR and EAS before they diverged; Ne of 500, 600, … 1,000 were simulated; N denotes no bottleneck was simulated.
Bottleneck occurred in EUR after the divergence of EUR and EAS, Ne of 100, 200, and 300 were simulated; N denotes no bottleneck was simulated.
Bottleneck occurred in EAS after the divergence of EUR and EAS, Ne of 100, 200, and 300 were simulated; N denotes no bottleneck was simulated.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.